Fanconi anemia is a highly penetrant cancer susceptibility syndrome.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Haematologica

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 18379006
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fanconi Anemia

  2019cited by this paper
• Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry

  2008cited by this paper
• Aberrant activation of stress-response pathways leads to TNF-alpha oversecretion in Fanconi anemia.

  2008cited by this paper
• Aberrant activation of stress-response pathways leads to TNF-α oversecretion in Fanconi anemia. Commentary

  2008cited by this paper
• Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.

  2007cited by this paper
• A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway.

  2007cited by this paper
• Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair.

  2007cited by this paper
• PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

  2007cited by this paper
• Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins

  2007cited by this paper
• Cancer Risks in Fanconi Anemia: Experience of the German Fanconi Anemia (GEFA) Registry.

  2006cited by this paper
• Fanconi anemia.

  2006cited by this paper
• Successful HSCT using nonradiotherapy-based conditioning regimens and alternative donors in patients with Fanconi anaemia – experience in a single UK centre

  2005cited by this paper
• Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes.

  2004cited by this paper
• Fanconi anaemia and leukaemia – clinical and molecular aspects

  2004cited by this paper
• Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors

  2004cited by this paper
• Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients.

  2004cited by this paper
• Abnormal telomere metabolism in Fanconi's anaemia correlates with genomic instability and the probability of developing severe aplastic anaemia

  2003cited by this paper
• Cancer incidence in persons with Fanconi anemia.

  2003cited by this paper
• Biallelic Inactivation of BRCA2 in Fanconi Anemia

  2002cited by this paper
• Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.

  2000cited by this paper
• Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study.

  1997cited by this paper

• Alcohol, stem cells and cancer

  2017influential citation
• Hematopoietic cell transplantation in Fanconi anemia and dyskeratosis congenita: A minireview.

  2017cites this paper
• Factors affecting the outcome of related allogeneic hematopoietic cell transplantation in patients with Fanconi Anemia.

  2014cites this paper
• Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia.

  2013cites this paper
• [Creation and report of the Tunisian Fanconi Anemia Registry (TFAR)].

  2012cites this paper
• Rola badań genetycznych w diagnostyce anemii aplastycznej u dziewczynki z wielowadziem i niedoborem wzrostu

  2011cites this paper
• Fanconi's anemia in dentistry: a case report and brief literature review

  2011cites this paper
• High prevalence of oral human papillomavirus infection in Fanconi's anemia patients.

  2011cites this paper
• Fanconi's anemia in dentistry: a case report and brief literature review Anemia de Fanconi em odontologia: relato de caso e breve revisão da literatura

  2011cites this paper
• Designing Targeted Therapies for Lymphomas and Leukemias

  2010cites this paper
• Elevated levels of IL-1beta in Fanconi anaemia group A patients due to a constitutively active phosphoinositide 3-kinase-Akt pathway are capable of promoting tumour cell proliferation.

  2009cites this paper
• [The survey of syndromes with the risk of cancer in children age].

  2009cites this paper